Illumina and Deerfield Management have entered into a five-year R&D partnership. The companies plan to apply a genetic-led approach to the discovery and development of novel therapies for diseases that present unmet medical needs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,